ARCHIVES

Phase III Tecemotide Trial Fails OS Endpoint; Second Trial Planned After Subgroup Analysis

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

New Patterns Of Care Study Okayed By DCT Board

June 13, 1986

Clearinghouse Group Selects 10 More Compounds To Test

January 13, 1978

NCI Programs: BSA Approves concept For Grants Program In Statistical Modeling

July 16, 1999

Partial Responses To Zactima In Thyroid Cancer Trial

January 27, 2006

Congress Insists On No Downward Negotiations; NCI May Drop 2000 To 300 Grants In FY 1991

November 9, 1990

Barakat Named Deputy Physician-in-Chief Of Memorial Sloan-Kettering’s Regional Care Network

October 18, 2013